Skip to main content
BIO KEY INTERNATIONAL INC logo

BIO KEY INTERNATIONAL INC — Investor Relations & Filings

Ticker · BKYI ISIN · US09060C3097 LEI · 549300VFT6WAQB4BVB07 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,005 across all filing types
Latest filing 2024-01-25 Major Shareholding Noti…
Country US United States of America
Listing US BKYI

About BIO KEY INTERNATIONAL INC

https://www.bio-key.com/

BIO KEY INTERNATIONAL INC is a provider of Identity and Access Management (IAM) and biometric identity solutions. The company develops technologies aimed at creating a secure, passwordless, and phishing-resistant environment for users. Its core offering is the PortalGuard platform, an IAM and Identity-as-a-Service (IDaaS) solution that provides multi-factor authentication (MFA), single sign-on (SSO), and self-service password reset capabilities. A key differentiator is its proprietary Identity-Bound Biometrics, particularly fingerprint identification technology, which is designed for rapid and accurate user verification. BIO-key offers flexible deployment options, including SaaS, hybrid, and on-premises, to support various organizational security strategies such as cloud migration and securing remote workforces.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G AMENDMENT NO. 1
Major Shareholding Notification
2024-01-25 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes that are important to shareholders. The content specifically discusses the company's compliance with Nasdaq's minimum bid price requirement and the closing of a prior non-compliance matter. There are no financial statements or detailed financial data presented, nor is this an announcement of a report publication. The document is an update on a regulatory compliance event, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Earnings Release or Capital Update. The document length is 3177 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2024-01-11 English
Regulatory Filings 2024
Regulatory Filings
2024-01-04 English
FORM 4
Director's Dealing
2024-01-03 English
FORM 4
Director's Dealing
2024-01-03 English
FORM 4
Director's Dealing
2024-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.